WHO Members Near Deal On IP, Innovation And Public Health, With Key Question
Some five years after setting a mandate to address barriers faced by poor countries in accessing needed medicines, World Health Organization members are near agreement on a strategy and plan of action. But a key question remains on WHO involvement in a possible treaty on biomedical research and development for diseases disproportionately affecting developing nations, and the WHO secretariat is facing accusations that the process has not been amply inclusive.
